• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾病与终末期肾病——一份为《欧盟健康状况:迈向更健康的欧洲》报告撰写的综述

Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.

作者信息

Zoccali Carmine, Kramer Anneke, Jager Kitty J

机构信息

CNR-IBIM Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Renal and Transplantation Unit, Ospedali Riuniti, Reggio Calabria, Italy.

ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

NDT Plus. 2010 Jun;3(3):213-224. doi: 10.1093/ndtplus/sfp127. Epub 2009 Oct 12.

DOI:10.1093/ndtplus/sfp127
PMID:28657040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5477935/
Abstract

The Report on the Status of Health in the European Union (EUGLOREH) is a project aimed at describing health problems in member states of the European Community. This project is an effort of more than 170 European experts and the collaboration of the health authorities or institutions from all EU Member States, major intergovernmental, International and European Organizations and Agencies. In this report, for the first time special emphasis is given to chronic diseases. Chronic kidney disease (CKD) is increasingly recognized as a major public health problem. However, with some notable exceptions, until now this disease has received scarce attention both at European level and at member states level. In 2007, the ERA-EDTA Registry was invited to contribute to EUGLOREH. The Registry made a major effort to gather published and unpublished information on the epidemiology of CKD and ESRD and to provide a comprehensive overview on CKD and ESRD in European countries. The review was completed in early 2008 and included into the final EUGLOREH published in the WEB as of 20 March 2009.

摘要

《欧盟健康状况报告》(EUGLOREH)是一个旨在描述欧盟成员国健康问题的项目。该项目由170多名欧洲专家共同努力,并得到了所有欧盟成员国、主要政府间组织、国际组织和欧洲组织及机构的卫生当局或机构的合作。在本报告中,首次特别强调了慢性病。慢性肾脏病(CKD)日益被视为一个主要的公共卫生问题。然而,除了一些明显的例外情况,到目前为止,这种疾病在欧洲层面和成员国层面都很少受到关注。2007年,ERA - EDTA注册中心受邀为EUGLOREH做出贡献。该注册中心做出了巨大努力,收集已发表和未发表的关于CKD和终末期肾病(ESRD)流行病学的信息,并对欧洲国家的CKD和ESRD提供全面概述。该综述于2008年初完成,并纳入了截至2009年3月20日在网上发布的最终EUGLOREH报告中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/4e7ecb1969d9/sfp127fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/27c72a94f6bc/sfp127fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/ed20ff09745b/sfp127fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/db22ce1a93fb/sfp127fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/4e7ecb1969d9/sfp127fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/27c72a94f6bc/sfp127fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/ed20ff09745b/sfp127fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/db22ce1a93fb/sfp127fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9315/5477935/4e7ecb1969d9/sfp127fig4.jpg

相似文献

1
Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.慢性肾病与终末期肾病——一份为《欧盟健康状况:迈向更健康的欧洲》报告撰写的综述
NDT Plus. 2010 Jun;3(3):213-224. doi: 10.1093/ndtplus/sfp127. Epub 2009 Oct 12.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Hemodialysis血液透析
4
Anniversary Oncology Days in Paris.巴黎周年肿瘤日。
Exp Oncol. 2023 Dec 28;45(3):273-274.
5
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
6
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.欧洲接受肾脏替代治疗的系统性硬化症(硬皮病)患者的特征和结局:来自 ERA-EDTA 登记处的结果。
Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.
7
Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry.考虑到在欧洲国家儿科终末期肾病中,生长激素的应用和处方存在较大差异——一项来自 ESPN/ERA-EDTA 注册研究的报告。
Nephrol Dial Transplant. 2016 Apr;31(4):609-19. doi: 10.1093/ndt/gfv105. Epub 2015 Apr 28.
8
The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies.欧盟与公共卫生紧急事件:应对 COVID-19 大流行第一波疫情的管理专家意见及对未来紧急事件的建议。
Front Public Health. 2021 Aug 20;9:698995. doi: 10.3389/fpubh.2021.698995. eCollection 2021.
9
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community.东欧肾脏病学界优化慢性肾脏病患者护理及以患者为导向研究的路线图。
Clin Kidney J. 2020 Dec 22;14(1):23-35. doi: 10.1093/ckj/sfaa218. eCollection 2021 Jan.
10
Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.氯沙坦降低终末期肾病的负担和成本:RENAAL研究对欧盟的公共卫生影响
Kidney Int Suppl. 2002 Dec(82):S68-72. doi: 10.1046/j.1523-1755.62.s82.14.x.

引用本文的文献

1
Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross-sectional study from Lorestan Province, Western Iran.血液透析患者中隐匿性丙型肝炎病毒感染(OCI)的患病率;来自伊朗西部洛雷斯坦省的一项横断面研究。
Virusdisease. 2024 Sep;35(3):478-483. doi: 10.1007/s13337-024-00881-y. Epub 2024 Aug 24.
2
Analysis of ABCB1 Gene Polymorphisms and Their Impact on Tacrolimus Blood Levels in Kidney Transplant Recipients.分析 ABCB1 基因多态性及其对肾移植受者他克莫司血药浓度的影响。
Int J Mol Sci. 2024 Oct 12;25(20):10999. doi: 10.3390/ijms252010999.
3
Glycosylation and Characterization of Human Transferrin in an End-Stage Kidney Disease.

本文引用的文献

1
How can we achieve global equity in provision of renal replacement therapy?我们如何在提供肾脏替代治疗方面实现全球公平?
Bull World Health Organ. 2008 Mar;86(3):229-37. doi: 10.2471/blt.07.041715.
2
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.意大利肾脏替代治疗的医疗保健组织与融资国际研究:一个不断演变的现实。
Int J Health Care Finance Econ. 2007 Sep;7(2-3):201-15. doi: 10.1007/s10754-007-9016-9.
3
Chronic kidney disease management in the United Kingdom: NEOERICA project results.
人转铁蛋白在终末期肾病中的糖基化及特性分析。
Int J Mol Sci. 2024 Apr 24;25(9):4625. doi: 10.3390/ijms25094625.
4
Chronic Kidney Disease Interplay with Comorbidities and Carbohydrate Metabolism: A Review.慢性肾脏病与合并症及碳水化合物代谢的相互作用:综述
Life (Basel). 2023 Dec 21;14(1):13. doi: 10.3390/life14010013.
5
Interaction of estradiol and renin-angiotensin system with microRNAs-21 and -29 in renal fibrosis: focus on TGF-β/smad signaling pathway.雌激素与肾素-血管紧张素系统与 microRNAs-21 和 -29 在肾纤维化中的相互作用:聚焦于 TGF-β/smad 信号通路。
Mol Biol Rep. 2024 Jan 18;51(1):137. doi: 10.1007/s11033-023-09127-4.
6
Joint modeling on serum creatinine and time to end stage of renal disease for chronic kidney disease patients under treatment at the University of Gondar Referral Hospital.对贡德尔大学转诊医院正在接受治疗的慢性肾病患者的血清肌酐和终末期肾病时间进行联合建模。
Health Sci Rep. 2023 Sep 17;6(9):e1563. doi: 10.1002/hsr2.1563. eCollection 2023 Sep.
7
Identification of Genetic Markers Linked to The Activity of Indoleamine 2,3-Dioxygenase and Kidney Function.与吲哚胺2,3-双加氧酶活性及肾功能相关的遗传标记物的鉴定
Metabolites. 2023 Apr 10;13(4):541. doi: 10.3390/metabo13040541.
8
Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients.代谢组学特征分析可明确区分终末期肾病患者和慢性肾脏病患者。
Sci Rep. 2023 Apr 15;13(1):6161. doi: 10.1038/s41598-023-33377-8.
9
Cognitive behavioural therapy self-help intervention preferences among informal caregivers of adults with chronic kidney disease: an online cross-sectional survey.认知行为疗法自助干预在慢性肾脏病成年患者非专业照护者中的偏好:一项在线横断面调查。
BMC Nephrol. 2023 Jan 4;24(1):4. doi: 10.1186/s12882-022-03052-7.
10
Silver nanoparticle modified surfaces induce differentiation of mouse kidney-derived stem cells.银纳米颗粒修饰的表面诱导小鼠肾源性干细胞分化。
RSC Adv. 2018 Jun 4;8(36):20334-20340. doi: 10.1039/c8ra02145g. eCollection 2018 May 30.
英国慢性肾脏病管理:NEOERICA项目结果
Kidney Int. 2007 Jul;72(1):92-9. doi: 10.1038/sj.ki.5002273. Epub 2007 Apr 18.
4
Food insecurity is associated with diabetes mellitus: results from the National Health Examination and Nutrition Examination Survey (NHANES) 1999-2002.粮食不安全与糖尿病有关:1999 - 2002年美国国家健康与营养检查调查(NHANES)的结果
J Gen Intern Med. 2007 Jul;22(7):1018-23. doi: 10.1007/s11606-007-0192-6. Epub 2007 Apr 11.
5
Clinical databases and the QUEST initiative.临床数据库与QUEST计划。
Blood Purif. 2007;25(3):219-20. doi: 10.1159/000101025. Epub 2007 Mar 23.
6
Has the rise in the incidence of renal replacement therapy in developed countries come to an end?发达国家肾脏替代治疗发病率的上升是否已告结束?
Nephrol Dial Transplant. 2007 Mar;22(3):678-80. doi: 10.1093/ndt/gfm060.
7
Chronic kidney disease in children: the global perspective.儿童慢性肾脏病:全球视角
Pediatr Nephrol. 2007 Dec;22(12):1999-2009. doi: 10.1007/s00467-006-0410-1. Epub 2007 Feb 20.
8
The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.明显健康人群的肾小球滤过率及其与10年心血管死亡率的关系。
Eur Heart J. 2007 Feb;28(4):478-83. doi: 10.1093/eurheartj/ehl455. Epub 2007 Jan 12.
9
Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III.代谢综合征的社会经济差异因性别而异:来自美国国家健康和营养检查调查(NHANES)III的证据。
Ann Epidemiol. 2007 Jan;17(1):19-26. doi: 10.1016/j.annepidem.2006.07.002. Epub 2006 Nov 29.
10
Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe.欧洲接受替代疗法患者的总体人群死亡率对南北死亡率梯度的影响。
Kidney Int. 2007 Jan;71(1):53-9. doi: 10.1038/sj.ki.5002008. Epub 2006 Nov 8.